Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Dec;97(50):e13697.
doi: 10.1097/MD.0000000000013697.

Cystic metastasis of prostate cancer: A case report

Affiliations
Case Reports

Cystic metastasis of prostate cancer: A case report

Bei Zhang et al. Medicine (Baltimore). 2018 Dec.

Abstract

Rationale: Prostate cancer often metastasizes (most commonly to the pelvic lymph nodes and axial skeleton); however, metastases to the pelvic cavity as a solitary mass are unusual. While metastatic prostate cancer is unconventional in pelvic cavity, cystic pelvic lesions are even more scarce. Accurate identification of cystic metastasis can be helpful in management of prostate cancer.

Patient concerns: A 64-year-old male was admitted to our hospital due to urethral irritation symptom and dysuria.

Diagnosis: In addition to prostate cancer, abdominal computed tomography (CT) scanning and magnetic resonance imaging (MRI) of the prostate revealed that a cystic mass was located at right pelvic cavity. Histopathological examination diagnosed the pelvic cystic mass as metastasis from prostatic cancer. Immunohistochemistry results demonstrated Calretinin (+), D2-40 (-), Ki-67 (10%+), Vimentin (-), CK-pan (+), CK5/6 (-), WT-1 (-), PSA (+), SALL4 (-), Villin (-), CK20 (-), CK7 (-), PAX-8 (-), and TTF-1 (-).

Interventions: The cystic mass was removed. Primary cancer of the prostate was reserved as well. After discharge, the patient underwent in a two-year androgen deprivation therapy (ADT) treatment.

Outcomes: After 13 months of discharge, no disease progression was found in the patient.

Lessons: Although cystic prostate cancer is rare, the occurrence possibility should be considered when cystic lesions are accompanied with prostate cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Abdominal CT scanning and MRI of the prostate. (A, B) The nonenhanced and arterial phase of abdominal CT axial scanning shows that a watery low density was located adjacent to the right iliac vessel. There was no obvious enhancement of the lesion in the arterial phase as well. (C) Venous phase of abdominal CT scanning exhibited that there was no significant enhancement in the cystic lesion of right lower abdomen. The enhancement of right part prostate is slightly obvious. (D) Fat-suppressed T2-weighted sequence presents low signal in the right portion of prostate. CT = computed tomography, MRI = magnetic resonance imaging.
Figure 2
Figure 2
Pathological and immunohistological results. (A) Gleason score was 4 + 3 = 7 (prognostic group III/V), tumor proportion (10/12 mm), and among them, Gleason 4 accounted for about 90% (HE, magnification: 100×). (B) Gleason score was 4 + 3 = 7 (prognostic group III/V), tumor proportion (10/12 mm), and among them, Gleason 4 accounted for about 90% (HE, magnification: 400×). (C) Papillary structure of tumor cells are shown in the upper part of the figure, while glomerular and glandular tubular structures are shown in the lower part (HE, magnification: 400×). (D) Papillary structure of tumor cells (HE, magnification: 400×). (E) Immunohistochemical PSA (+) is shown. (F) Immunohistochemical CK-pan (+) is shown.

Similar articles

Cited by

References

    1. Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin 2018;68:284–96. - PMC - PubMed
    1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115–32. - PubMed
    1. Shou J, Zhang Q, Wang S, et al. The prognosis of different distant metastases pattern in prostate cancer: a population based retrospective study. Prostate 2018;78:491–7. - PubMed
    1. Tsuji H, Hashimoto K, Katoh Y, et al. Prostatic cancer with huge cystic degeneration. Urol Int 1999;62:48–50. - PubMed
    1. Takayama H, Arai Y, Meguro N, et al. Prostatic cancer with cystic formation: a case report. Hinyokika Kiyo 1996;42:977–80. - PubMed

Publication types

Substances